Skip to content
Screener

Claritev Corporation CTEV Investing Cash Flow

Investing Cash Flow at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$6.7M+88.9%
UnitedHealth Group logo
UnitedHealth GroupUNH
-$1.8B-24.7%
Conduent Incorporated logo
Conduent IncorporatedCNDT
-$12M-138%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
-$6.22M-107%
Corvel logo
CorvelCRVL
-$6.84M+55.8%
Phreesia logo
PhreesiaPHR
$4.8M+165%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net cash provided by operating activities46,89231,181
Investing activities:
Purchases of property and equipment(84,847)(63,489)
Net cash used in investing activities(84,847)(63,489)
Financing activities:
Repayments of Term Loan(7,346)(3,674)
Taxes paid on settlement of vested share awards(2,863)(2,884)
Borrowings on 2025 Revolving Credit Facility170,000130,000

Item 1. Financial Statements

FAQ

What is Claritev Corporation's investing cash flow?
Claritev Corporation (CTEV) reported investing cash flow of -$38.08M in Q2 2026.
How has Claritev Corporation's investing cash flow changed year-over-year?
Claritev Corporation's investing cash flow decreased by 54.7% year-over-year, from -$24.62M to -$38.08M.
What is the long-term trend for Claritev Corporation's investing cash flow?
Over 4 years (2021 to 2025), Claritev Corporation's investing cash flow has grown at a -14.7% compound annual growth rate (CAGR), from -$228.38M to -$121.02M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Claritev Corporation's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude